Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takehiro Takahashi

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
The Journal of Dermatology|January 19, 2016
Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosisKouki Nakamura, Yoshihide Asano, Takashi Taniguchi, et al.
Modern Rheumatology|October 22, 2011
Improvement of endothelial function in parallel with the amelioration of dry cough and dyspnea due to interstitial pneumonia by intravenous cyclophosphamide pulse therapy in patients with systemic sclerosis: a preliminary report of two casesTakehiro Takahashi, Yoshihide Asano, Eisuke Amiya, et al.
The Journal of Dermatology|October 6, 2018
Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational studyHayakazu Sumida, Yoshihide Asano, Zenshiro Tamaki, et al.
Modern Rheumatology|May 7, 2011
Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangreneYohei Ichimura, Yoshihide Asano, Masaru Hatano, et al.
Rheumatology International|October 22, 2013
Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosisYuri Masui, Yoshihide Asano, Kaname Akamata, et al.
Rheumatology (Oxford, England)|December 26, 2014
Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosisKaname Akamata, Yoshihide Asano, Takashi Taniguchi, et al.
Nature Communications|December 16, 2014
Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosisShinji Noda, Yoshihide Asano, Satoshi Nishimura, et al.
Modern Rheumatology|April 2, 2013
Clinical correlation of brachial artery flow-mediated dilation in patients with systemic sclerosisTakehiro Takahashi, Yoshihide Asano, Eisuke Amiya, et al.
Modern Rheumatology|May 22, 2012
Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosisYuri Masui, Yoshihide Asano, Takehiro Takahashi, et al.
The Journal of Dermatology|February 28, 2015
Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosisRyosuke Saigusa, Yoshihide Asano, Kouki Nakamura, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
The Journal of Dermatology|January 19, 2016
Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosisKouki Nakamura, Yoshihide Asano, Takashi Taniguchi, et al.
Modern Rheumatology|October 22, 2011
Improvement of endothelial function in parallel with the amelioration of dry cough and dyspnea due to interstitial pneumonia by intravenous cyclophosphamide pulse therapy in patients with systemic sclerosis: a preliminary report of two casesTakehiro Takahashi, Yoshihide Asano, Eisuke Amiya, et al.
The Journal of Dermatology|October 6, 2018
Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational studyHayakazu Sumida, Yoshihide Asano, Zenshiro Tamaki, et al.
Modern Rheumatology|May 7, 2011
Significant attenuation of macrovascular involvement by bosentan in a patient with diffuse cutaneous systemic sclerosis with multiple digital ulcers and gangreneYohei Ichimura, Yoshihide Asano, Masaru Hatano, et al.
Rheumatology International|October 22, 2013
Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosisYuri Masui, Yoshihide Asano, Kaname Akamata, et al.
Rheumatology (Oxford, England)|December 26, 2014
Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosisKaname Akamata, Yoshihide Asano, Takashi Taniguchi, et al.
Nature Communications|December 16, 2014
Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosisShinji Noda, Yoshihide Asano, Satoshi Nishimura, et al.
Modern Rheumatology|April 2, 2013
Clinical correlation of brachial artery flow-mediated dilation in patients with systemic sclerosisTakehiro Takahashi, Yoshihide Asano, Eisuke Amiya, et al.
Modern Rheumatology|May 22, 2012
Clinical significance of monitoring serum adiponectin levels during intravenous pulse cyclophosphamide therapy in interstitial lung disease associated with systemic sclerosisYuri Masui, Yoshihide Asano, Takehiro Takahashi, et al.
The Journal of Dermatology|February 28, 2015
Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosisRyosuke Saigusa, Yoshihide Asano, Kouki Nakamura, et al.
Pageof 14